E
EMYRIA LTD
ASX: EMD (EMYRIAL FPO [EMD])
Last update: yesterday, 8:19AM0.068
0.00 (1.49%)
| Previous Close | 0.067 |
| Open | 0.069 |
| Volume | 6,252,293 |
| Avg. Volume (3M) | 4,512,622 |
| Market Cap | 45,227,188 |
| Price / Sales | 24.67 |
| Price / Book | 9.02 |
| 52 Weeks Range | |
| Earnings Date | 28 Jul 2025 - 1 Aug 2025 |
| Profit Margin | -92.08% |
| Operating Margin (TTM) | -86.92% |
| Diluted EPS (TTM) | 0.000 |
| Quarterly Revenue Growth (YOY) | -39.60% |
| Total Debt/Equity (MRQ) | 23.53% |
| Current Ratio (MRQ) | 2.03 |
| Operating Cash Flow (TTM) | -4.28 M |
| Levered Free Cash Flow (TTM) | -2.19 M |
| Return on Assets (TTM) | -10.14% |
| Return on Equity (TTM) | -74.80% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Health Information Services (AU) | Mixed | Mixed |
| Health Information Services (Global) | Bullish | Mixed | |
| Stock | EMYRIAL FPO [EMD] | - | - |
AIStockmoo Score
0.1
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | -5.0 |
| Technical Moving Averages | 1.5 |
| Technical Oscillators | 4.0 |
| Average | 0.13 |
|
Emyria Ltd operates a network of specialist medical clinics and uses purpose-built software and technology to gather clinical data from consenting patients. It operates in one segment of research and development. |
|
| Sector | Healthcare |
| Industry | Health Information Services |
| Investment Style | Small Growth |
| % Held by Insiders | 34.78% |
| % Held by Institutions | 3.89% |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |